Amalgamated Bank’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,315
Closed -$10K 2617
2025
Q4
$10K Buy
1,315
+90
+7% +$575 ﹤0.01% 2432
2025
Q3
$4K Hold
1,225
﹤0.01% 2860
2025
Q2
$5K Hold
1,225
﹤0.01% 2787
2025
Q1
$3K Buy
1,225
+470
+62% +$1.32K ﹤0.01% 2804
2024
Q4
$3K Hold
755
﹤0.01% 2872
2024
Q3
$5K Hold
755
﹤0.01% 2778
2024
Q2
$5K Hold
755
﹤0.01% 2801
2024
Q1
$4K Sell
755
-2,331
-76% -$11K ﹤0.01% 2795
2023
Q4
$16K Sell
3,086
-225
-7% -$694 ﹤0.01% 2751
2023
Q3
$11K Hold
3,311
﹤0.01% 2880
2023
Q2
$27K Buy
3,311
+935
+39% +$8.42K ﹤0.01% 2592
2023
Q1
$21K Sell
2,376
-430
-15% -$4.77K ﹤0.01% 2633
2022
Q4
$34K Hold
2,806
﹤0.01% 2594
2022
Q3
$18K Buy
2,806
+5
+0.2% +$42 ﹤0.01% 2841
2022
Q2
$25K Buy
2,801
+113
+4% +$995 ﹤0.01% 2798
2022
Q1
$31K Buy
+2,688
New +$41.4K ﹤0.01% 2664

Other funds holding SGHT

Amalgamated Bank's SGHT Position: Q1 2026 in Review

Amalgamated Bank sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 1,315 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in SGHT in Q1 2022 and held it in 16 quarters. The position peaked at $34K in Q4 2022. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Amalgamated Bank reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,315 Sight Sciences shares in Q1 2026, an estimated $10K.
  • Amalgamated Bank first reported a position in Sight Sciences in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Sight Sciences position peaked at $34K in Q4 2022.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.